Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

Tuberculosis (TB) kills more people than any other pathogen and the only licenced vaccine, BCG, is ineffective in most of the world. There is an urgent need for a better vaccine, but TB vaccine development is scientifically challenging. An update on global progress in TB vaccine R&D, together with an overview of the development of a TB controlled human infection model using BCG will be given.
The development of a vaccine against SARS CoV2 was happily much easier than TB vaccine development. However, a SARS CoV2 controlled human infection model would still have utility in drug and vaccine R&D and an overview of the status of a SARS CoV2 controlled human infection model will also be provided.

Helen McShane FRCP, PhD, FMedSci is Director, NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, University of Oxford; Deputy Head, Medical Sciences Division and an Honorary Consultant Physician in Infectious Diseases.

Since 2001, Helen has lead the TB vaccine research group at the University of Oxford, and has expertise in vaccine design through to phase IIb efficacy testing. She led the development of the first candidate TB vaccine to enter efficacy testing, and now works on alternate routes of delivery and the development of controlled human infection models for TB and SARS CoV2.

 

University members only.

Forthcoming events

Gut microbiome

Monday, 28 April 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Malaria and febrile coma cohort study

Monday, 12 May 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The meningococcal B vaccine journey and beyond

Monday, 19 May 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Avian and human influenza

Monday, 02 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Better treatment for tuberculosis

Monday, 09 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The burden of drug resistant infections, the GRAM project

Monday, 16 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms